Orion OYJ (OTCMKTS:ORINY) Announces Earnings Results

Orion OYJ (OTCMKTS:ORINY) posted its quarterly earnings results on Wednesday. The company reported $0.68 EPS for the quarter, Zacks reports.

Orion OYJ Stock Performance

OTCMKTS ORINY traded down $0.78 on Wednesday, reaching $54.00. The company had a trading volume of 900 shares, compared to its average volume of 1,249. Orion OYJ has a 12 month low of $30.89 and a 12 month high of $56.05. The firm’s 50 day moving average price is $47.15 and its 200 day moving average price is $41.36.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded Orion OYJ from a “hold” rating to a “strong-buy” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy”.

About Orion OYJ

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes prescription medicines, over-the-counter products, generic pharmaceuticals and active pharmaceutical ingredients.

The company focuses on several therapeutic areas, including central nervous system disorders, oncology, respiratory diseases, pain management and veterinary medicine. Orion is particularly recognized for treatments related to Parkinson’s disease, as well as its Easyhaler line of inhaled medicines for respiratory conditions.

Founded in Finland in 1917, Orion is headquartered in Espoo.